Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

31 Mar 2025 Evaluate
Aurobindo Pharma has informed that it has disclosed the receipt of the above referred cautionary e-mails to the stock exchanges on March 28, 2025. The company has submitted the disclosure again in the prescribed format as Annexure to this letter.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..